2015
DOI: 10.15585/mmwr.mm6444a5
|View full text |Cite
|
Sign up to set email alerts
|

Global Routine Vaccination Coverage, 2014

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
34
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(34 citation statements)
references
References 5 publications
0
34
0
Order By: Relevance
“…The Global Vaccine Action Plan specified 2015 targets as 90% national coverage with DTP3 and coverage of at least 80% in all districts worldwide [8]. However, many countries still fall short of these targets [9]. Research has been undertaken in a number of SSA countries to identify the determinants of childhood vaccination coverage [1015].…”
Section: Introductionmentioning
confidence: 99%
“…The Global Vaccine Action Plan specified 2015 targets as 90% national coverage with DTP3 and coverage of at least 80% in all districts worldwide [8]. However, many countries still fall short of these targets [9]. Research has been undertaken in a number of SSA countries to identify the determinants of childhood vaccination coverage [1015].…”
Section: Introductionmentioning
confidence: 99%
“…13 WHO recommends integrating vaccinations given during health service contacts where possible, and opportunities to provide the WHO-recommended TTCV booster doses increasingly exist as countries introduce a second dose of measles-containing vaccine (MCV2) during the second year of life (2YL) and work to develop robust school-based programs for new vaccines that target preadolescents, such as human papillomavirus virus vaccine. 3,26,27 Kenya, Tanzania, and Mozambique have established national 2YL delivery platforms with the introduction of MCV2 within the past 3 years. MCV2 coverage by the end of the 2YL in Tanzania improved from 29% in 2014 to 57% in 2015, whereas MCV2 coverage in Kenya was 28% in 2015; data were unavailable for Mozambique where MCV2 was introduced in 2015.…”
mentioning
confidence: 99%
“…The BCG vaccine has been used worldwide for routine vaccination against tuberculosis, and the estimated coverage of the target age population was >90% of in 2014 . Adverse events have been reported after BCG vaccination in 0.01–5% of recipients.…”
Section: Discussionmentioning
confidence: 99%